Chesterfield, MO, United States of America

Gabrielle R Neises



Average Co-Inventor Count = 4.0

ph-index = 10

Forward Citations = 285(Granted Patents)


Location History:

  • Chesterfield, GB (1996)
  • Chesterfield, MO (US) (1995 - 2001)

Company Filing History:


Years Active: 1995-2001

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Gabrielle R Neises: Innovator in Glycolipid Synthesis and Tay-Sachs Treatment

Introduction

Gabrielle R Neises is a prominent inventor based in Chesterfield, MO (US). She has made significant contributions to the field of biochemistry, particularly in the development of novel compounds for medical applications. With a total of 10 patents, her work has had a substantial impact on the treatment of genetic disorders.

Latest Patents

Among her latest patents, Neises has developed deoxygalactonojirimycin derivatives. These novel N-alkyl derivatives contain alkyl groups with 3-6 carbon atoms and are useful for selectively inhibiting glycolipid synthesis. Additionally, she has disclosed a method for treating Tay-Sachs disease, which involves subjecting cells to a glycolipid inhibitory effective amount of an N-alkyl derivative of 1,5-dideoxy-1,5-imino-D-glucitol, where the alkyl contains 2-8 carbon atoms.

Career Highlights

Throughout her career, Neises has worked with notable companies such as Monsanto Company and G.D. Searle & Company. Her experience in these organizations has allowed her to refine her expertise in biochemistry and patent development.

Collaborations

Some of her notable coworkers include Frances M Platt and Raymond A Dwek. Their collaborative efforts have contributed to advancements in the field and have furthered the impact of Neises's inventions.

Conclusion

Gabrielle R Neises is a trailblazer in the field of biochemistry, with a focus on innovative treatments for genetic disorders. Her contributions through her patents and collaborations continue to influence the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…